Healthcare Value Capital’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Healthcare Value Capital’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$31K	–	13
2018 Q3	$31K	Hold	1	–	–	0.08%	12
2018 Q2	$39K	Hold	1	–	–	0.11%	13
2018 Q1	$41K	Hold	1	–	–	0.17%	9
2017 Q4	$184K	Buy	+1	New	+$200K	0.56%	9
2016 Q4	–	Hold	0	–	-$149K	–	25
2016 Q3	–	Hold	0	–	–	–	19
2016 Q2	–	Hold	0	–	–	–	23
2016 Q1	–	Hold	0	–	–	–	28
2015 Q4	–	Sell	-1	Closed	-$1.43M	–	20
2015 Q3	$949K	Hold	1	–	–	1.35%	17
2015 Q2	$1.11M	Buy	+1	New	+$1.91M	1.17%	19
2015 Q1	–	Hold	0	–	–	–	20

Other funds holding SEEL

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Healthcare Value Capital's SEEL Position: Q4 2018 in Review

Healthcare Value Capital sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2018, closing a stake of 1 share — an estimated $31K sold.

Healthcare Value Capital first reported a position in SEEL in Q2 2015 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 7 funds tracked by Wall St. Rank hold SEEL as of Q4 2018.

Healthcare Value Capital reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Healthcare Value Capital sold 1 Seelos Therapeutics, Inc. Common Stock share in Q4 2018, an estimated $31K.
Healthcare Value Capital first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
Healthcare Value Capital's Seelos Therapeutics, Inc. Common Stock position peaked at $1.11M in Q2 2015.
7 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Healthcare Value Capital's 13F filing for Q4 2018, filed 13 Feb 2019.